LDR | |
02202cam a2200421 i 4500 |
001 |
|
000210777 |
003 |
|
MiAaHDL |
005 |
|
20110215000000.0 |
006 |
|
m d |
007 |
|
cr bn ---auaua |
008 |
|
770222s1976 mdua b f100 0 eng |
010 |
⊔ |
⊔ |
‡a 76602693
|
016 |
7 |
⊔ |
‡a7700307
‡2DNLM
|
019 |
⊔ |
⊔ |
‡a2342896
‡a35299994
|
035 |
⊔ |
⊔ |
‡asdr-pur2606680
|
035 |
⊔ |
⊔ |
‡asdr-miu.990002107770106381
|
035 |
⊔ |
⊔ |
‡a2606680
|
035 |
⊔ |
⊔ |
‡a(OCoLC)2819589
|
040 |
⊔ |
⊔ |
‡aDLC
‡cDLC
‡dGPO
‡dNLM
‡dOCL
‡dBTCTA
‡dOCLCG
‡dBUF
‡dAMAZN
|
049 |
⊔ |
⊔ |
‡aIPL1
|
050 |
1 |
4 |
‡aQV183 S989d 1975
|
050 |
0 |
0 |
‡aRM666.D37
‡bS93 1975
|
060 |
0 |
0 |
‡aQV 183
‡bS989d 1975
|
082 |
0 |
0 |
‡a616.1/52
|
086 |
0 |
⊔ |
‡aHE 20.3302:C 41
|
111 |
2 |
⊔ |
‡aSymposium on Development of Iron Chelators for Clinical Use
‡n(1st :
‡d1975 :
‡cNational Institutes of Health)
|
245 |
1 |
0 |
‡aDevelopment of iron chelators for clinical use :
‡bproceedings of a symposium, September 22, 1975, Bethesda, Maryland /
‡ceditors, W. French Anderson, Merilyn C. Hiller.
|
260 |
⊔ |
⊔ |
‡a[Bethesda, Md.] :
‡bU.S. Dept. of Health, Education, and Welfare, Public Health Service, National Institutes of Health, National Institute of Arthritis, Metabolism, and Digestive Diseases,
‡c[1976]
|
300 |
⊔ |
⊔ |
‡a277 p. :
‡bill. ;
‡c27 cm.
|
490 |
0 |
⊔ |
‡aDHEW publication ; no. (NIH) 76-994
|
504 |
⊔ |
⊔ |
‡aIncludes bibliographical references.
|
538 |
⊔ |
⊔ |
‡aMode of access: Internet.
|
650 |
⊔ |
2 |
‡aIron Chelating Agents
‡vCongresses.
|
650 |
⊔ |
0 |
‡aMicrobial metabolites
‡vCongresses.
|
650 |
⊔ |
0 |
‡aIron in the body
‡vCongresses.
|
650 |
⊔ |
0 |
‡aIron chelates
‡xPhysiological effect
‡vCongresses.
|
650 |
⊔ |
0 |
‡aDeferoxamine
‡xTherapeutic use
‡vCongresses.
|
700 |
1 |
⊔ |
‡aHiller, Merilyn C.
|
700 |
1 |
⊔ |
‡aAnderson, W. French,
‡d1936-
|
710 |
2 |
⊔ |
‡aNational Institute of Arthritis, Metabolism, and Digestive Diseases (U.S.)
|
776 |
0 |
8 |
‡iOnline version:
‡aSymposium on Development of Iron Chelators for Clinical Use. (1st : 1975 : National Institutes of Health)
‡tDevelopment of iron chelators for clinical use.
‡d[Bethesda, Md.] : U.S. Dept. of Health, Education, and Welfare, Public Health Service, National Institutes of Health, National Institute of Arthritis, Metabolism, and Digestive Diseases, [1976]
‡w(OCoLC)557928463
|
CID |
⊔ |
⊔ |
‡a000210777
|
DAT |
0 |
⊔ |
‡a20101018003007.0
‡b20110215000000.0
|
DAT |
1 |
⊔ |
‡a20120815064345.0
‡b2024-09-29T18:26:40Z
|
DAT |
2 |
⊔ |
‡a2024-09-29T17:30:02Z
|
CAT |
⊔ |
⊔ |
‡aSDR-PUR
‡dUNKNOWN
‡lloader.pl-001-001
|
FMT |
⊔ |
⊔ |
‡aBK
|
HOL |
⊔ |
⊔ |
‡0sdr-pur2606680
‡apur1
‡bSDR
‡cPUR
‡ppur1.32754081177937
‡sPUR
‡12606680
|
974 |
⊔ |
⊔ |
‡bPUR
‡cPUR
‡d20240929
‡sgoogle
‡upur1.32754081177937
‡y1976
‡rpd
‡qbib
‡tUS fed doc
|
974 |
⊔ |
⊔ |
‡bMIU
‡cMIU
‡d20230625
‡sgoogle
‡umdp.39015002428178
‡y1976
‡rpd
‡qbib
‡tUS fed doc
|